Invention Grant
- Patent Title: Alpha-D-galactoside inhibitors of galectins
-
Application No.: US16313628Application Date: 2017-07-09
-
Publication No.: US10889610B2Publication Date: 2021-01-12
- Inventor: Fredrik Zetterberg , Ulf Nilsson , Hakon Leffler
- Applicant: GALECTO BIOTECH AB
- Applicant Address: DK Copenhagen
- Assignee: GALECTO BIOTECH AB
- Current Assignee: GALECTO BIOTECH AB
- Current Assignee Address: DK Copenhagen
- Agency: Maier & Maier, PLLC
- Priority: EP16179070 20160712
- International Application: PCT/EP2017/067181 WO 20170709
- International Announcement: WO2018/011094 WO 20180118
- Main IPC: C07H19/056
- IPC: C07H19/056 ; A61K31/7056 ; C07H19/12
Abstract:
The present invention relates to a compound of the general formula (1). The compound of formula (1) is suitable for use in a method for treating a disorder relating to the binding of a galectin, such as galectin-3 to a ligand in a mammal, such as a human. Furthermore, the present invention concerns a method for treatment of a disorder relating to the binding of a galectin, such as galectin-3 to a ligand in a mammal, such as a human.
Public/Granted literature
- US20190315793A1 ALPHA-D-GALACTOSIDE INHIBITORS OF GALECTINS Public/Granted day:2019-10-17
Information query
IPC分类:
